Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 312.50 | 257.33 | 504.00 | 414.50 | 1.2159 | 1.6576 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 312.50 | 257.33 | 449.00 | 414.50 | 1.0832 | 1.2466 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 312.50 | 257.33 | 294.00 | 414.50 | 0.7093 | 0.2137 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 312.50 | 257.33 | 1010.00 | 414.50 | 2.4367 | 6.3022 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 312.50 | 257.33 | 497.00 | 414.50 | 1.1990 | 1.6041 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 312.50 | 257.33 | 508.00 | 414.50 | 1.2256 | 1.6883 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 312.50 | 257.33 | 407.00 | 414.50 | 0.9819 | 0.9476 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 312.50 | 257.33 | 425.00 | 414.50 | 1.0253 | 1.0741 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 312.50 | 257.33 | 807.00 | 414.50 | 1.9469 | 4.2694 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 312.50 | 257.33 | 436.00 | 414.50 | 1.0519 | 1.1526 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 312.50 | 257.33 | 230.00 | 414.50 | 0.5549 | -0.1507 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 352.00 | 414.50 | 0.8492 | 0.5770 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 266.00 | 414.50 | 0.6417 | 0.0493 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 374.00 | 414.50 | 0.9023 | 0.7223 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 316.00 | 414.50 | 0.7624 | 0.3480 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 312.50 | 257.33 | 315.00 | 414.50 | 0.7600 | 0.3418 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 312.50 | 257.33 | 460.00 | 414.50 | 1.1098 | 1.3270 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 418.00 | 414.50 | 1.0084 | 1.0246 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 312.50 | 257.33 | 188.00 | 414.50 | 0.4536 | -0.3665 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 502.00 | 414.50 | 1.2111 | 1.6423 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 312.50 | 257.33 | 386.00 | 414.50 | 0.9312 | 0.8032 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 257.33 | 547.00 | 414.50 | 1.3197 | 1.9936 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 312.50 | 257.33 | 583.00 | 414.50 | 1.4065 | 2.2843 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 312.50 | 257.33 | 475.00 | 414.50 | 1.1460 | 1.4382 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 312.50 | 257.33 | 492.00 | 414.50 | 1.1870 | 1.5661 |